Inventor · disambiguated record
Claudia Tessmer
Also filed as: TESSMER CLAUDIA
4 granted patents·7 pending applications·13 citations·filing 1993–2025
69Inventor score
Files withDEUTSCHES KREBSFORSCH4DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS4DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS3
Top patents by PatentIndex Score
11 records- 0172US7713712B2Antibodies active against a fusion polypeptide comprising a histidine portionDEUTSCHES KREBSFORSCH·Filed 2009·Granted May 11, 2010·1 cites·2 claims
- 0268US2025271436A1Use of bmmf1 rep protein as a biomarker for prostate cancerDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS·Filed 2025·Application pending·0 cites
- 0364US2025067740A1Use of bmmf1 rep protein as diagnostic marker for lung cancerDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2024·Application pending·0 cites
- 0464US2025067744A1Use of bmmf1 rep protein as diagnostic marker for pancreatic cancer and diabetes mellitus type 2DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2024·Application pending·0 cites
- 0561US2022091125A1Use of bmmfi rep protein as a biomarker for prostate cancerDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS·Filed 2021·Application pending·0 cites
- 0657US2004105854A1Antibodies active against a fusion polypeptide comprising a histidine portionDEUTSCHES KREBSFORSCH·Filed 2003·Application pending·0 cites
- 0755US12282020B2Use of BMMFI Rep protein as biomarker for colorectal cancerDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2020·Granted Apr 22, 2025·0 cites·4 claims
- 0854US6790940B1Antibodies active against a fusion polypeptide comprising a histidine portionDEUTSCHES KREBSFORSCH·Filed 1996·Granted Sep 14, 2004·8 cites·1 claims
- 0947US2022034890A1Use of bmmf1 rep protein as a biomarker for breast cancerDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS·Filed 2021·Application pending·0 cites
- 1046US2025262296A1Modified oncolytic parvovirus h-1pv with an enhanced fitness and superior anticancer activityDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS·Filed 2025·Application pending·0 cites
- 1127US6051384AMethod of detecting p53-specific antibodiesDEUTSCHES KREBSFORSCH·Filed 1993·Granted Apr 18, 2000·4 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Claudia Tessmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →